淋巴瘤的放射性配体疗法:过去、现在和未来。

IF 3 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
{"title":"淋巴瘤的放射性配体疗法:过去、现在和未来。","authors":"","doi":"10.1016/j.cpet.2024.05.003","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":46670,"journal":{"name":"PET Clinics","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Radioligand Therapy in Lymphoma\",\"authors\":\"\",\"doi\":\"10.1016/j.cpet.2024.05.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":46670,\"journal\":{\"name\":\"PET Clinics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PET Clinics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S155685982400049X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PET Clinics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S155685982400049X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

20 世纪 80 年代,放射性标记细胞有助于了解血液肿瘤学的病理。20 世纪 90 年代,临床前试验评估了使用单克隆抗体(MoAbs)的放射性标记免疫疗法,如使用碘-131(Bexxar)或钇-90(Zevalin)标记的抗 CD20 制剂。由于放射性标记的 MoAbs 具有安全、持久的疗效,美国食品和药物管理局在 2000 年代批准了这些药物。尽管放射免疫疗法走过了漫长的历程,但其应用最近却有所减少。本综述将讨论放射免疫疗法的历史进程、优势与困难的辩论以及试验探索。我们将探讨放射配体疗法在血液肿瘤学中的未来发展方向,考虑可能成为下一个治疗趋势的新兴分子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Radioligand Therapy in Lymphoma
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
PET Clinics
PET Clinics RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
5.70
自引率
3.80%
发文量
78
期刊介绍: As the clinical applications of positron emission tomography (PET) increase, the new PET Clinics brings together the combined expertise of leading authorities in the field to provide you incisive clinical reviews on advances in the use of PET and combined PET/CT. Published quarterly, PET Clinics provides concise, practical guidance on the clinical issues you face every day. It examines PET is effectiveness in cancer diagnosis and staging, as well as exploring PET is usefulness in the areas of dementia, myocardial viability, and other conditions. Full-color images featured throughout. Topics covered include Breast Cancer, Alzheimer is Disease and Dementia, Lymphoma, Lung Cancer, Cardiology, Pediatric Applications, Infection and Inflammation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信